Outcomes after cessation of mepolizumab therapy in severe eosinophilic asthma: A 12-month follow-up analysis
| Main Authors: | , , , , , , , , , , |
|---|---|
| Format: | Journal article |
| Published: |
2014
|
| _version_ | 1797105638520651776 |
|---|---|
| author | Haldar, P Haldar, P Brightling, C Brightling, C Singapuri, A Hargadon, B Gupta, S Gupta, S Monteiro, W Bradding, P Bradding, P Green, R Wardlaw, A Wardlaw, A Ortega, H Pavord, I |
| author_facet | Haldar, P Haldar, P Brightling, C Brightling, C Singapuri, A Hargadon, B Gupta, S Gupta, S Monteiro, W Bradding, P Bradding, P Green, R Wardlaw, A Wardlaw, A Ortega, H Pavord, I |
| author_sort | Haldar, P |
| collection | OXFORD |
| description | |
| first_indexed | 2024-03-07T06:50:13Z |
| format | Journal article |
| id | oxford-uuid:fc4f2226-7459-45d8-ac5f-af123d74fa07 |
| institution | University of Oxford |
| last_indexed | 2024-03-07T06:50:13Z |
| publishDate | 2014 |
| record_format | dspace |
| spelling | oxford-uuid:fc4f2226-7459-45d8-ac5f-af123d74fa072022-03-27T13:19:44ZOutcomes after cessation of mepolizumab therapy in severe eosinophilic asthma: A 12-month follow-up analysisJournal articlehttp://purl.org/coar/resource_type/c_dcae04bcuuid:fc4f2226-7459-45d8-ac5f-af123d74fa07Symplectic Elements at Oxford2014Haldar, PHaldar, PBrightling, CBrightling, CSingapuri, AHargadon, BGupta, SGupta, SMonteiro, WBradding, PBradding, PGreen, RWardlaw, AWardlaw, AOrtega, HPavord, I |
| spellingShingle | Haldar, P Haldar, P Brightling, C Brightling, C Singapuri, A Hargadon, B Gupta, S Gupta, S Monteiro, W Bradding, P Bradding, P Green, R Wardlaw, A Wardlaw, A Ortega, H Pavord, I Outcomes after cessation of mepolizumab therapy in severe eosinophilic asthma: A 12-month follow-up analysis |
| title | Outcomes after cessation of mepolizumab therapy in severe eosinophilic asthma: A 12-month follow-up analysis |
| title_full | Outcomes after cessation of mepolizumab therapy in severe eosinophilic asthma: A 12-month follow-up analysis |
| title_fullStr | Outcomes after cessation of mepolizumab therapy in severe eosinophilic asthma: A 12-month follow-up analysis |
| title_full_unstemmed | Outcomes after cessation of mepolizumab therapy in severe eosinophilic asthma: A 12-month follow-up analysis |
| title_short | Outcomes after cessation of mepolizumab therapy in severe eosinophilic asthma: A 12-month follow-up analysis |
| title_sort | outcomes after cessation of mepolizumab therapy in severe eosinophilic asthma a 12 month follow up analysis |
| work_keys_str_mv | AT haldarp outcomesaftercessationofmepolizumabtherapyinsevereeosinophilicasthmaa12monthfollowupanalysis AT haldarp outcomesaftercessationofmepolizumabtherapyinsevereeosinophilicasthmaa12monthfollowupanalysis AT brightlingc outcomesaftercessationofmepolizumabtherapyinsevereeosinophilicasthmaa12monthfollowupanalysis AT brightlingc outcomesaftercessationofmepolizumabtherapyinsevereeosinophilicasthmaa12monthfollowupanalysis AT singapuria outcomesaftercessationofmepolizumabtherapyinsevereeosinophilicasthmaa12monthfollowupanalysis AT hargadonb outcomesaftercessationofmepolizumabtherapyinsevereeosinophilicasthmaa12monthfollowupanalysis AT guptas outcomesaftercessationofmepolizumabtherapyinsevereeosinophilicasthmaa12monthfollowupanalysis AT guptas outcomesaftercessationofmepolizumabtherapyinsevereeosinophilicasthmaa12monthfollowupanalysis AT monteirow outcomesaftercessationofmepolizumabtherapyinsevereeosinophilicasthmaa12monthfollowupanalysis AT braddingp outcomesaftercessationofmepolizumabtherapyinsevereeosinophilicasthmaa12monthfollowupanalysis AT braddingp outcomesaftercessationofmepolizumabtherapyinsevereeosinophilicasthmaa12monthfollowupanalysis AT greenr outcomesaftercessationofmepolizumabtherapyinsevereeosinophilicasthmaa12monthfollowupanalysis AT wardlawa outcomesaftercessationofmepolizumabtherapyinsevereeosinophilicasthmaa12monthfollowupanalysis AT wardlawa outcomesaftercessationofmepolizumabtherapyinsevereeosinophilicasthmaa12monthfollowupanalysis AT ortegah outcomesaftercessationofmepolizumabtherapyinsevereeosinophilicasthmaa12monthfollowupanalysis AT pavordi outcomesaftercessationofmepolizumabtherapyinsevereeosinophilicasthmaa12monthfollowupanalysis |